25 May 2013
Keywords: gsk, lamictal, cleared, wider, pediatric, use, food
Article | 27 January 2003
The US Food and Drug Administration has approved a new pediatricindication for GlaxoSmithKline's anti-epileptic drug Lamictal
(lamotrigine). The product is ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 January 2003
24 May 2013
© 2013 thepharmaletter.com